2023 Utah Code › Title 58 - Occupations and Professions › Chapter 38a - Controlled Substances Advisory Committee Act › Part 2 - Controlled Substances Advisory Committee › Section 204 - Guidelines for scheduling or listing drugs.

58-38a-204.
Guidelines for scheduling or listing drugs.
(1)
(a) The committee shall recommend placement of a substance in Schedule I if it finds:
(i) that the substance has high potential for abuse; and
(ii) that an accepted standard has not been established for safe use in treatment for medical purposes.
(b) The committee may recommend placement of a substance in Schedule I under Section 58-37-4 if it finds that the substance is classified as a controlled substance in Schedule I under federal law.
(2)
(a) The committee shall recommend placement of a substance in Schedule II if it finds that:
(i) the substance has high potential for abuse;
(ii) the substance has a currently accepted medical use in treatment in the United States, or a currently accepted medical use subject to severe restrictions; and
(iii) the abuse of the substance may lead to severe psychological or physiological dependence.
(b) The committee may recommend placement of a substance in Schedule II if it finds that the substance is classified as a controlled substance in Schedule II under federal law.
(3)
(a) The committee shall recommend placement of a substance in Schedule III if it finds that:
(i) the substance has a potential for abuse that is less than the potential for substances listed in Schedules I and II;
(ii) the substance has a currently accepted medical use in treatment in the United States; and
(iii) abuse of the substance may lead to moderate or low physiological dependence or high psychological dependence.
(b) The committee may recommend placement of a substance in Schedule III if it finds that the substance is classified as a controlled substance in Schedule III under federal law.
(4)
(a) The committee shall recommend placement of a substance in Schedule IV if it finds that:
(i) the substance has a low potential for abuse relative to substances in Schedule III;
(ii) the substance has currently accepted medical use in treatment in the United States; and
(iii) abuse of the substance may lead to limited physiological dependence or psychological dependence relative to the substances in Schedule III.
(b) The committee may recommend placement of a substance in Schedule IV if it finds that the substance is classified as a controlled substance in Schedule IV under federal law.
(5)
(a) The committee shall recommend placement of a substance in Schedule V if it finds that:
(i) the substance has low potential for abuse relative to the controlled substances listed in Schedule IV;
(ii) the substance has currently accepted medical use in treatment in the United States; and
(iii) the substance has limited physiological dependence or psychological dependence liability relative to the controlled substances listed in Schedule IV.
(b) The committee may recommend placement of a substance in Schedule V under this chapter if it finds that the substance is classified as a controlled substance in Schedule V under federal law.
(6) The committee may recommend placement of a substance on a controlled substance list if it finds that the substance has a potential for abuse and that an accepted standard has not been established for safe use in treatment for medical purposes.
Amended by Chapter 12, 2011 General Session